1-12 of 12
Roger Belizaire
Close
Sort by
Journal Articles

Sensitivity to Targeted UBA1 Inhibition in a Myeloid Cell Line Model of Vexas Syndrome

Adriana Chiaramida, Sandra G. Obwar, Gabriel K. Griffin, Anja E.H. Nordstrom, Maria Ericsson, Dilshad H. Khan, Roger Belizaire
Journal: Blood
Blood (2023) 142 (Supplement 1): 939.
https://doi.org/10.1182/blood-2023-179447
Published: 2023
Journal Articles

To Fe, or not to Fe, that is the question

Roger Belizaire, Sean R. Stowell
Journal: Blood
Blood (2022) 140 (25): 2658–2660.
https://doi.org/10.1182/blood.2022017881
Published: 2022
Journal Articles

UBR5 Is a Hect E3 Ubiquitin Ligase That Regulates Chromatin Bound Nuclear Hormone Receptor Stability

Jonathan M Tsai, Jacob D Aguirre, Jared Brown, Vivian Focht, Yen-Der Li, Georg Kempf, Lukas Kater, Pius Galli, Simone Cavadini, Brittany E Sandoval, Charles Zou, Justine Rutter, Katherine Donovan, Quinlan Sievers, Paul Park, Jevon A. Cutler, Charlie Hatton, Elizabeth Ener, Micah T Sperling, Mikolaj Slabicki, Peter G. Miller, Roger Belizaire, Adam S. Sperling, Scott A. Armstrong, Eric S. Fischer, Nicolas Thomä, Benjamin L. Ebert
Journal: Blood
Blood (2022) 140 (Supplement 1): 2968–2969.
https://doi.org/10.1182/blood-2022-167615
Published: 2022
Journal Articles

Splicing Modulators Impair DNA Damage Response and Induce Killing of Cohesin-Mutant MDS/AML

Emily C Wheeler, Benjamin Martin, William Doyle, Rebecca Gorelov, Melanie Donahue, Johann-Christoph Jann, Omar Abdel-Wahab, Justin Taylor, Michael Seiler, Silvia Buonamici, Roger Belizaire, Karen Adelman, Zuzana Tothova
Journal: Blood
Blood (2022) 140 (Supplement 1): 6888–6889.
https://doi.org/10.1182/blood-2022-170996
Published: 2022
Journal Articles

CBL mutations drive PI3K/AKT signaling via increased interaction with LYN and PIK3R1

Roger Belizaire, Sebastian H. J. Koochaki, Namrata D. Udeshi, Alexis Vedder, Lei Sun, Tanya Svinkina, Christina Hartigan, Marie McConkey, Veronica Kovalcik, Amanuel Bizuayehu, Caroline Stanclift, Monica Schenone, Steven A. Carr, Eric Padron, Benjamin L. Ebert
Journal: Blood
Blood (2021) 137 (16): 2209–2220.
https://doi.org/10.1182/blood.2020006528
Published: 2021
Includes: Supplemental data
Journal Articles

Incidence and Risk Factors for Bleeding in Patients with Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy

Jurjen Versluis, Yael Flamand, MS, Erika J. Haydu, MD PhD, Rahul S. Vedula, MD, Anne Charles, BS, Kevin Copson, MA, Ofir Wolach, MD, Pavan Bendapudi, MD, Roger Belizaire, MD PhD, Donna S. Neuberg, ScD, Marlise R Luskin, MDMS, R. Coleman Lindsley, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 12–13.
https://doi.org/10.1182/blood-2020-137741
Published: 2020
Journal Articles

Oncogenic Mechanisms of CBL E3 Ubiquitin Ligase Mutations in Myeloid Malignancies

Roger Belizaire, MD PhD, Sebastian Koochaki, BS, MS, Namrata Udeshi, PhD, Alexis Vedder, BS, Lei Sun, Monica Schenone, PhD, Steven Carr, PhD, Eric Padron, MD, Benjamin L. Ebert, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 563.
https://doi.org/10.1182/blood-2019-122503
Published: 2019
Journal Articles

Low-Dose Interleukin-2 Therapy Enhances Cytotoxicity of CD56 bright NK Cells in Patients with Chronic Gvhd

Tomohiro Kubo, MD PhD, Rizwan Romee, MD, John Koreth, MBBS, DPhil, Roger Belizaire, MD PhD, Yusuke Kamihara, MD PhD, Hongye Liu, PhD, Takeru Asano, MDPhD, Jennifer Whangbo, MD PhD, Masahiro Hirakawa, MD PhD, Sarah Nikiforow, MD PhD, Mahasweta Gooptu, MD, Vincent T. Ho, MD, Corey S. Cutler, MD MPH, Edwin P. Alyea, III, MD, Joseph H. Antin, MD, Robert J. Soiffer, MD, Jerome Ritz, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 606.
https://doi.org/10.1182/blood-2018-99-109918
Published: 2018
Journal Articles

Extra-Corporeal Photopheresis Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-Vs.-Host Disease: Efficacy, Safety and Immune Correlates

John Koreth, MBBS, DPhil, Haesook T Kim, PhD, Roger Belizaire, MD PhD, Samuel J Poryanda, BSc, Carol Reynolds, PhD, Jennifer Whangbo, MD PhD, Sarah Nikiforow, Edwin Alyea, III, MD, Philippe Armand, MD PhD, Corey Cutler, MD MPH, FRCPC, Vincent T Ho, MD, Bruce Blazar, MD, Joseph H. Antin, MD, Jerome Ritz, MD, Robert J. Soiffer, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 515.
https://doi.org/10.1182/blood.V130.Suppl_1.515.515
Published: 2017
Journal Articles

Generation of Models of Human Hematologic Malignancies Using CRISPR Genome Engineering

Zuzana Tothova, MD PhD, John M Krill-Burger, MCS, Katerina D Popova, BA, Quinlan Sievers, BA, David Yudovich, BSc, Roger Belizaire, MD PhD, Jon C. Aster, MD PhD, Elizabeth A. Morgan, MD, Aviad Tsherniak, MSc, Benjamin L Ebert, MD PhD
Journal: Blood
Blood (2016) 128 (22): 741.
https://doi.org/10.1182/blood.V128.22.741.741
Published: 2016
Journal Articles

Flow Cytometric Evaluation Of Minimal Residual Disease In Adult Acute Lymphoblastic Leukemia Using a Simplified, Single-Tube Approach

Roger Belizaire, MD, PhD, Olga Pozdnyakova, MD, PhD, Daniel J. DeAngelo, MD, PhD, Betty Li, MS, MT(ASCP), Karry Charest, MT(ASCP), Richard M. Stone, MD, Martha Wadleigh, MD, David P. Steensma, MD, Gabriela Motyckova, MD, PhD, David M. Dorfman, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1378.
https://doi.org/10.1182/blood.V122.21.1378.1378
Published: 2013
Journal Articles

ITAM signaling in dendritic cells controls T helper cell priming by regulating MHC class II recycling

Daniel B. Graham, Holly M. Akilesh, Grzegorz B. Gmyrek, Laura Piccio, Susan Gilfillan, Julia Sim, Roger Belizaire, Javier A. Carrero, Yinan Wang, Gregory S. Blaufuss, Gabriel Sandoval, Keiko Fujikawa, Anne H. Cross, John H. Russell, Marina Cella, Wojciech Swat
Journal: Blood
Blood (2010) 116 (17): 3208–3218.
https://doi.org/10.1182/blood-2009-10-250415
Published: 2010
Includes: Supplemental data